.Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CX02_Clonidine.Clonidine .Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CX02_Clonidine.Clonidine| name: | Clonidine |
| ATC code: | N02CX02 | route: | oral |
| n-compartments | 2 |
Clonidine is an alpha-2 adrenergic agonist used for the treatment of hypertension, attention deficit hyperactivity disorder (ADHD), and occasionally for management of withdrawal symptoms or pain. It remains approved and in use for these indications today.
Pharmacokinetic parameters reported for healthy adult volunteers after oral tablet administration.
Larsson, P, et al., & Anderson, BJ (2011). Oral bioavailability of clonidine in children. Paediatric anaesthesia 21(3) 335–340. DOI:10.1111/j.1460-9592.2010.03397.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/20735802
De Hondt, L, et al., & Tommelein, E (2024). Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review. Frontiers in public health 12 1437328–None. DOI:10.3389/fpubh.2024.1437328 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39171321
Bienert, A, et al., & Grześkowiak, E (2015). Melatonin and clonidine premedication has similar impact on the pharmacokinetics and pharmacodynamics of propofol target controlled-infusions. Journal of clinical pharmacology 55(3) 307–316. DOI:10.1002/jcph.401 PUBMED:https://pubmed.ncbi.nlm.nih.gov/25243731